When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. - Wikidata - awgldk - TriplyDB

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

http://www.wikidata.org/entity/Q33876261

about

Prevention of HIV-1 infection with early antiretroviral therapy Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal Effects Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States Modeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimes Risk factors for delayed entrance into care after diagnosis among patients with late-stage HIV disease in southern Vietnam Measurement Error and Environmental Epidemiology: A Policy Perspective Ending the pandemic: reducing new HIV infections to zero Can we trust the guidelines? Comparison between the data presented and the recommendations of the International Antiviral Society-USA Panel Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy Scaling up antiretroviral treatment and improving patient retention in care: lessons from Ethiopia, 2005-2013.Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study HIV stigma among substance abusing people living with HIV/AIDS: implications for HIV treatment.Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations Evaluation of the duplication of staging CT scans for localized colon cancer in a Medicare population.Attrition through multiple stages of pre-treatment and ART HIV care in South Africa Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.A multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York City Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era.Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study.When to start antiretroviral therapy: the need for an evidence base during early HIV infection Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.Antiretroviral therapy: when to start Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand.Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients.HIV infection, immunodeficiency, viral replication, and the risk of cancer.Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study.

P2860

Q24634688-492D2ACA-5636-4FF2-8AEA-ADCF7A86EDD1 Q26774666-FEF48270-A0DB-49C5-860C-4466F22C3A5B Q28386534-ECD8C784-01E0-4A28-857A-5810CA50665C Q28387887-79885735-B84E-473E-BD93-0CD1DF4EE9ED Q28484046-8CD81FD4-E0A1-4A39-9FA8-AB6650E0FF58 Q28543860-8C39CECD-5B3C-4316-ACDC-2F478263DF48 Q29248055-7233B5F0-C45F-4043-8A45-708BEB2957F0 Q30356525-B08E9514-CD6A-4C6A-839A-D54D655F4B31 Q30869836-4A642E66-96A1-4B95-8CD5-9519AC60BC85 Q33654668-FD4A7260-0B87-4C38-943C-4B42361F1C50 Q33714596-DB3FED8B-011D-417C-9F53-23E58DFBE01D Q33717359-8510C2A6-EF8D-4D0E-83E2-D97DA61AA2E2 Q33775397-85C8EF4B-6857-4670-B7BA-4B23267F5F4A Q33784615-6FA0602E-6CEC-4312-8AB6-46D103ABDF26 Q33980748-E95A1355-673A-44E6-B304-2C8F9EAED88F Q34086963-52037EDC-C4F2-41E6-A232-68A1CDB55449 Q34263117-8D7955F8-C80E-4FC0-AAF8-41BD3FBFD48E Q34280961-0586CDF4-9905-411A-88F1-984FCA601B59 Q34321843-0A7A4896-034B-482D-8E71-9724035F2C7F Q34339066-F990B2D0-DA9E-4CAA-B3C3-1B61C95536F2 Q34374074-45475789-C610-4E56-8C41-F65AA3A38F9A Q34379806-7F9E12C4-6213-4E80-85CC-21EDEB606F9F Q34387168-3F5969B2-ED23-4D14-BC12-5F7EBB2ED223 Q34398159-47BB9959-F918-417B-88C2-A353186B2C89 Q34485916-6194D497-D885-440A-8C39-57B2EB2A7EC5 Q34629153-4A54BD0C-FD71-4EF6-9947-36BF257D1D87 Q34662516-267B7E38-71EC-4147-B100-24C425E48400 Q34663606-E2095F36-ED3A-468A-8F24-23E0635DB207 Q34702924-850950BE-2517-45B3-A87E-944D52EF5584 Q34773308-0344FE60-DDE0-4DBA-B6BE-B018A88EA5D4 Q34926786-84F5D85C-95EC-455D-9ED0-ABCA874216BF Q35124919-126A18C9-FA87-42C0-BCB4-A10837538BF8 Q35142189-B70ED2E1-AF66-450C-93C4-62FCC379144C Q35204279-1C840F8F-7639-478C-9802-D391D9E3815E Q35470434-929FFA34-0D8A-450C-824C-CE2B061AC0A3 Q35530299-BEBE1250-65C8-428E-8A1D-B98D8C706442 Q35589224-36FC2EDF-6019-409A-A151-9C583D32F4A1 Q35612742-4A311529-CEB6-490F-9AC7-5DD3E0AD110A Q35794099-AE53584B-DD21-4EAE-A831-A9AB79704443 Q35837001-39BB26F1-F865-42AE-BD2B-1526D7D5BCF8

P2860

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

http://www.wikidata.org/entity/Q33876261

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

When to initiate combined anti ...... tries: an observational study.

@ast

When to initiate combined anti ...... tries: an observational study.

@en

type

label

When to initiate combined anti ...... tries: an observational study.

@ast

When to initiate combined anti ...... tries: an observational study.

@en

prefLabel

When to initiate combined anti ...... tries: an observational study.

@ast

When to initiate combined anti ...... tries: an observational study.

@en

P1433

Q33876261-94B7036A-BCE4-4AF2-B667-1429D1AF9A57

P1476

Q33876261-ACAEACBD-47AD-4E63-8D04-E57EA657DCB7

P2093

Q33876261-133CBDCA-E089-4CF9-8998-03693E371C34

Q33876261-20D79704-4218-454F-BC0D-42E1B984CA03

Q33876261-306D19F1-8C22-48F5-8667-73D3847033BE

Q33876261-3C419095-F1D8-415D-A787-68EF7C896FF2

Q33876261-43FF8DFA-5737-472F-B1D7-034F78E635C9

Q33876261-75223EB7-E4A0-4915-8240-169AD5F95F95

Q33876261-79301527-BE8A-4BE0-AFEC-7747AD56DA8A

Q33876261-8E636E5C-3965-4EE8-AE5A-601E3CB06CEE

Q33876261-8F01BFDD-88B7-4F72-B2BC-DCF8A2A75475

Q33876261-B50CB4F1-A136-4C31-9A4B-86654F9F6890

P2860

Q33876261-021779D3-68CC-4120-9E81-C45576333A86

Q33876261-04EF4731-6DED-4C37-BF93-A64B93CB9479

Q33876261-05A3EBC9-6386-4788-84E4-1E338E0D499A

Q33876261-0A9421BF-E2D0-4A70-88C4-A67DA0FBA674

Q33876261-1AFF0E00-9476-4F4E-92E9-E4DF05E77C08

Q33876261-1F0A9E07-CD29-4562-9FDF-18DDA5668AB3

Q33876261-1F14AD78-882B-4CFC-99D3-C030E86FB0D4

Q33876261-2D46FBD8-3FD8-48D4-A5F6-D14C9C512DA6

Q33876261-2EFD6591-AD43-4020-ACB0-CFF07551BD1E

Q33876261-321CF0A7-F83E-43B1-88DF-309BFAFB360D

P304

Q33876261-D77CC722-ED9E-4875-A850-66E14ED17822

P31

Q33876261-5AB79584-4737-47C2-9072-68C2650FDA0F

P356

Q33876261-94D9BBAE-9DC8-4A24-9730-19EC16B1808D

P407

Q33876261-ED2D0F65-9A49-42B1-BBFB-4A626B7A56FD

P433

Q33876261-946D27D4-8732-4E06-9BA4-76C742B02D77

P478

Q33876261-C17ABFF4-EE61-43BB-95CE-D50A743C059E

P50

Q33876261-2FFD8A46-5E41-41C6-A98A-30070DC5FE2B

Q33876261-537E1ED8-3AE1-4270-95F0-6E4F8DF95630

Q33876261-81F7CDD4-FC71-45BD-B4FD-8A66FAE1AD5E

Q33876261-A3F87572-19FF-4EC2-9466-AA11D9C5A514

Q33876261-AB7B3D49-17C3-41FB-981D-458783D59F40

Q33876261-ACAC249A-D5FB-4A9E-849B-7DFA97FCB799

P577

Q33876261-32A01108-40B8-4186-8106-010E56CE1290

P698

Q33876261-6F54726D-5737-49A9-85B8-D177849D6113

P921

Q33876261-657CEB50-2118-463C-B406-0E96D5708174

P932

Q33876261-DAEB4CE3-7C36-4FD0-BAF3-6EF0CFF39C92

P356

0003-4819-154-8-201104190-00001

P1433

Annals of Internal Medicine

P1476

When to initiate combined anti ...... tries: an observational study.

@en

P2093

Amy Justice

http://www.w3.org/2001/XMLSchema#string

Anna Esteve

http://www.w3.org/2001/XMLSchema#string

Emilie Lanoy

http://www.w3.org/2001/XMLSchema#string

Frank de Wolf

http://www.w3.org/2001/XMLSchema#string

HIV-CAUSAL Collaboration

http://www.w3.org/2001/XMLSchema#string

Heiner C Bucher

http://www.w3.org/2001/XMLSchema#string

James M Robins

http://www.w3.org/2001/XMLSchema#string

Jonathan A C Sterne

http://www.w3.org/2001/XMLSchema#string

Jordi Casabona

http://www.w3.org/2001/XMLSchema#string

Joseph Goulet

http://www.w3.org/2001/XMLSchema#string

P2860

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

CD4+ count-guided interruption of antiretroviral treatment

Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

Effect of early versus deferred antiretroviral therapy for HIV on survival.

A structural approach to selection bias.

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

P304

509-515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-154-8-201104190-00001

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

154

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Costagliola

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21502648

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3610527

http://www.w3.org/2001/XMLSchema#string